Finance

Lists
A1ZN34:BVMF
Astrazeneca Plc Bdr
၁၃၉.၉၀ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၆, GMT-၃ ၁၇:၀၆:၀၀  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1ZN34...
Open
၁၄၃.၃၃ R$
High
၁၄၃.၃၃ R$
Low
၁၃၈.၈၁ R$
Mkt. cap
ဋေ ၂.၅၉ သ
Avg. vol.
၈၉၂.၀၀
Volume
၁.၂၅ ထောင်
52-wk high
၁၉၀.၄၀ R$
52-wk low
၁၂၉.၀၆ R$
Shares outstanding
၁၅၅.၀၉ ဋေ
No. of employees
၁ သိန်း
Open
၁၄၃.၃၃ R$
High
၁၄၃.၃၃ R$
Low
၁၃၈.၈၁ R$
Mkt. cap
ဋေ ၂.၅၉ သ
Avg. vol.
၈၉၂.၀၀
Volume
၁.၂၅ ထောင်
52-wk high
၁၉၀.၄၀ R$
52-wk low
၁၂၉.၀၆ R$
Shares outstanding
၁၅၅.၀၉ ဋေ
No. of employees
၁ သိန်း
News stories
From web sources and news partners
The Twelfth Magpie
The Twelfth Magpie
·
ပြီးခဲ့သည့် ၂ ရက်
While the market panics about the FTSE 100, Citi just raised its AstraZeneca target to £186
JournalArta
JournalArta
·
ပြီးခဲ့သည့် ၂ ရက်
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
Euronext Markets: Real-time Stock Market Data | live
Euronext Markets: Real-time Stock Market Data | live
·
ပြီးခဲ့သည့် ၃ ရက်
AstraZeneca strikes $40 million AI drug discovery deal with insitro
BioSpace
BioSpace
·
ပြီးခဲ့သည့် ၃ ရက်
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees၉.၆၁ သောင်း
Founded၁၉၉၉ ဧ ၆
Headquartersကိန်းဘရစ်ချ်မြို့, Cambridgeshire, ယူနိုက်တက်ကင်းဒမ်း
Sector-
Next call ၁၂ ရက်အတွင်း
အောက် ၃၀ သောကြာ, ၁၆:၃၀
Fiscal period
Q3 2026
- / ၂.၅၇ US$
Revenue / Est. (USD)
- / ဋေ ၁.၆၀ ထ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၅၂ ထ
ဋေ ၁.၅၅ ထ
ဋေ ၁.၅၃ ထ
ဋေ ၁.၅၄ ထ
Cost of goods sold
၂၇၉.၂၀ ဋေ
၃၁၇.၀၀ ဋေ
၂၆၇.၃၀ ဋေ
၂၅၃.၁၀ ဋေ
Cost of revenue
၂၇၉.၂၀ ဋေ
၃၁၇.၀၀ ဋေ
၂၆၇.၃၀ ဋေ
၂၅၃.၁၀ ဋေ
Research and development expenses
၃၆၃.၀၀ ဋေ
၃၆၁.၅၀ ဋေ
၃၄၇.၁၀ ဋေ
၃၆၇.၂၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅၁၉.၆၀ ဋေ
၅၃၁.၈၀ ဋေ
၅၀၂.၇၀ ဋေ
၅၇၂.၄၀ ဋေ
Operating expense
၈၇၃.၇၀ ဋေ
၈၉၈.၆၀ ဋေ
၈၃၄.၃၀ ဋေ
၉၂၄.၄၀ ဋေ
Total operating expenses
ဋေ ၁.၁၅ ထ
ဋေ ၁.၂၂ ထ
ဋေ ၁.၁၀ ထ
ဋေ ၁.၁၈ ထ
Operating income
၃၆၆.၂၀ ဋေ
၃၃၄.၇၀ ဋေ
၄၂၇.၂၀ ဋေ
၃၆၀.၉၀ ဋေ
Other non operating income
-
-၂၄.၇၀ ကုဋေ
-
-
EBT including unusual items
၃၂၄.၄၀ ဋေ
၂၆၂.၉၀ ဋေ
၃၉၁.၄၀ ဋေ
၂၇၉.၉၀ ဋေ
EBT excluding unusual items
၃၃၂.၃၀ ဋေ
၃၀၄.၉၀ ဋေ
၃၉၄.၀၀ ဋေ
၃၂၄.၄၀ ဋေ
Income tax expense
၇၀.၉၀ ကုဋေ
၃၀.၀၀ ကုဋေ
၈၃.၃၀ ကုဋေ
၂၉.၁၀ ကုဋေ
Effective tax rate
၂၁.၈၆%
၁၁.၄၁%
၂၁.၂၈%
၁၀.၄၀%
Other operating expenses
-၈.၉၀ ကုဋေ
၅.၃၀ ကုဋေ
-၁၅.၅၀ ကုဋေ
-၁၅.၂၀ ကုဋေ
Net income
၂၅၃.၃၀ ဋေ
၂၃၂.၆၀ ဋေ
၃၀၈.၀၀ ဋေ
၂၅၀.၇၀ ဋေ
Net profit margin
၁၆.၆၇%
၁၅.၀၀%
၂၀.၁၅%
၁၆.၃၀%
Earnings per share
၂.၃၈
၂.၁၂
၁.၂၉
၂.၆၃
Interest and investment income
၈.၅၀ ကုဋေ
၁၃.၅၀ ကုဋေ
၇.၃၀ ကုဋေ
၈.၀၀ ကုဋေ
Interest expense
-၄၃.၄၀ ကုဋေ
-၁၅.၅၀ ကုဋေ
-၃၉.၃၀ ကုဋေ
-၄၃.၅၀ ကုဋေ
Net interest expenses
-၃၄.၉၀ ကုဋေ
-၂.၀၀ ကုဋေ
-၃၂.၀၀ ကုဋေ
-၃၅.၅၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၅၂၁.၁၀ ဋေ
၄၁၁.၃၀ ဋေ
၅၆၃.၈၀ ဋေ
၅၁၉.၃၀ ဋေ
Gain or loss from assets sale
-၃.၁၀ ကုဋေ
-၃.၇၀ ကုဋေ
-၃.၄၀ ကုဋေ
-၉.၄၀ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ